Dishman Seeks $25 Million For Newly Open China Production Facility
This article was originally published in PharmAsia News
Executive Summary
Dishman Pharmaceuticals and Chemicals is offering its plant in China for sale even as it begins production of intermediates after years of regulatory delays.